Pharmacogenetic-Directed Treatment for Major Depression

NCT01261364 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Depression

Interventions

BEHAVIORAL: GeneSightRx
BEHAVIORAL: Treatment as usual

Sponsor

Assurex Health Inc.

Collaborators

[object Object]